Japan lodges complaint against Novartis

Share this article:

Japan is filing a criminal complaint against Novartis and its ads for blood pressure medication Diovan. The Japan Times reports that the health ministry's complaint alleges exaggerated advertising, following a September health ministry finding that the company leveraged information from reports that were later discredited for false claims that the drug reduced the risk of cerebral stroke and angina.

The Japan Times says promotional materials for Diovan cited these reports around 700 times. The drug launched in Japan in 2000. Two universities involved in the studies announced in July 2013 that the data had been manipulated.

Novartis has said that it did not know the data was falsified.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.